Loading...
Lobe Sciences Ltd.
LOBE.CN•CNQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.07
$-0.00(-6.67%)
Canadian Market opens in 16h 38mLobe Sciences Ltd. (LOBE.CN) AI-Powered Stock Analysis
See how Lobe Sciences Ltd. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerLobe Sciences Ltd. (LOBE.CN) Stock Overall Grade
Lobe Sciences Ltd.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Lobe Sciences Ltd.'s overall stock rating.
Forecast
C+Score
55/100Financial Growth
AScore
80/100Fundamental Growth
C+Score
57/100Key Ratios
B+Score
70/100Sector Comparison
A+Score
100/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
94/100Analyst Consensus
C+Score
50/100Lobe Sciences Ltd. (LOBE.CN) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 55/100 (C+), reflecting weak confidence in its potential. Financial Growth (80/100, A) and Fundamental Growth (57/100, C+) highlight its stability, while Key Ratios (70/100, B+) and Sector Comparison (100/100, A+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (94/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Lobe Sciences Ltd. stock grade, including financials, comparisons, and forecasts.